report cover

Oral Nonsteroidal Anti-Inflammatory Drugs Market, Global Outlook and Forecast 2025-2032

  • 31 July 2025
  • Life Sciences
  • 121 Pages
  • Report code : 24WT-8053637

Oral Nonsteroidal Anti-Inflammatory Drugs and Forecast Market

1 Introduction to Research & Analysis Reports
1.1 Oral Nonsteroidal Anti-Inflammatory Drugs Market Definition
1.2 Market Segments
1.2.1 Segment by Type
1.2.2 Segment by Application
1.3 Global Oral Nonsteroidal Anti-Inflammatory Drugs Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 Global Oral Nonsteroidal Anti-Inflammatory Drugs Overall Market Size
2.1 Global Oral Nonsteroidal Anti-Inflammatory Drugs Market Size: 2024 VS 2032
2.2 Global Oral Nonsteroidal Anti-Inflammatory Drugs Market Size, Prospects & Forecasts: 2020-2032
2.3 Global Oral Nonsteroidal Anti-Inflammatory Drugs Sales: 2020-2032
3 Company Landscape
3.1 Top Oral Nonsteroidal Anti-Inflammatory Drugs Players in Global Market
3.2 Top Global Oral Nonsteroidal Anti-Inflammatory Drugs Companies Ranked by Revenue
3.3 Global Oral Nonsteroidal Anti-Inflammatory Drugs Revenue by Companies
3.4 Global Oral Nonsteroidal Anti-Inflammatory Drugs Sales by Companies
3.5 Global Oral Nonsteroidal Anti-Inflammatory Drugs Price by Manufacturer (2020-2025)
3.6 Top 3 and Top 5 Oral Nonsteroidal Anti-Inflammatory Drugs Companies in Global Market, by Revenue in 2024
3.7 Global Manufacturers Oral Nonsteroidal Anti-Inflammatory Drugs Product Type
3.8 Tier 1, Tier 2, and Tier 3 Oral Nonsteroidal Anti-Inflammatory Drugs Players in Global Market
3.8.1 List of Global Tier 1 Oral Nonsteroidal Anti-Inflammatory Drugs Companies
3.8.2 List of Global Tier 2 and Tier 3 Oral Nonsteroidal Anti-Inflammatory Drugs Companies
4 Sights by Product
4.1 Overview
4.1.1 Segment by Type - Global Oral Nonsteroidal Anti-Inflammatory Drugs Market Size Markets, 2024 & 2032
4.1.2 Penecillins
4.1.3 Cephalosporins
4.1.4 Tetracyclins
4.1.5 Sulfonamides
4.1.6 Other
4.2 Segment by Type - Global Oral Nonsteroidal Anti-Inflammatory Drugs Revenue & Forecasts
4.2.1 Segment by Type - Global Oral Nonsteroidal Anti-Inflammatory Drugs Revenue, 2020-2025
4.2.2 Segment by Type - Global Oral Nonsteroidal Anti-Inflammatory Drugs Revenue, 2026-2032
4.2.3 Segment by Type - Global Oral Nonsteroidal Anti-Inflammatory Drugs Revenue Market Share, 2020-2032
4.3 Segment by Type - Global Oral Nonsteroidal Anti-Inflammatory Drugs Sales & Forecasts
4.3.1 Segment by Type - Global Oral Nonsteroidal Anti-Inflammatory Drugs Sales, 2020-2025
4.3.2 Segment by Type - Global Oral Nonsteroidal Anti-Inflammatory Drugs Sales, 2026-2032
4.3.3 Segment by Type - Global Oral Nonsteroidal Anti-Inflammatory Drugs Sales Market Share, 2020-2032
4.4 Segment by Type - Global Oral Nonsteroidal Anti-Inflammatory Drugs Price (Manufacturers Selling Prices), 2020-2032
5 Sights by Application
5.1 Overview
5.1.1 Segment by Application - Global Oral Nonsteroidal Anti-Inflammatory Drugs Market Size, 2024 & 2032
5.1.2 Sterilization
5.1.3 Bacteriostasis
5.2 Segment by Application - Global Oral Nonsteroidal Anti-Inflammatory Drugs Revenue & Forecasts
5.2.1 Segment by Application - Global Oral Nonsteroidal Anti-Inflammatory Drugs Revenue, 2020-2025
5.2.2 Segment by Application - Global Oral Nonsteroidal Anti-Inflammatory Drugs Revenue, 2026-2032
5.2.3 Segment by Application - Global Oral Nonsteroidal Anti-Inflammatory Drugs Revenue Market Share, 2020-2032
5.3 Segment by Application - Global Oral Nonsteroidal Anti-Inflammatory Drugs Sales & Forecasts
5.3.1 Segment by Application - Global Oral Nonsteroidal Anti-Inflammatory Drugs Sales, 2020-2025
5.3.2 Segment by Application - Global Oral Nonsteroidal Anti-Inflammatory Drugs Sales, 2026-2032
5.3.3 Segment by Application - Global Oral Nonsteroidal Anti-Inflammatory Drugs Sales Market Share, 2020-2032
5.4 Segment by Application - Global Oral Nonsteroidal Anti-Inflammatory Drugs Price (Manufacturers Selling Prices), 2020-2032
6 Sights by Region
6.1 By Region - Global Oral Nonsteroidal Anti-Inflammatory Drugs Market Size, 2024 & 2032
6.2 By Region - Global Oral Nonsteroidal Anti-Inflammatory Drugs Revenue & Forecasts
6.2.1 By Region - Global Oral Nonsteroidal Anti-Inflammatory Drugs Revenue, 2020-2025
6.2.2 By Region - Global Oral Nonsteroidal Anti-Inflammatory Drugs Revenue, 2026-2032
6.2.3 By Region - Global Oral Nonsteroidal Anti-Inflammatory Drugs Revenue Market Share, 2020-2032
6.3 By Region - Global Oral Nonsteroidal Anti-Inflammatory Drugs Sales & Forecasts
6.3.1 By Region - Global Oral Nonsteroidal Anti-Inflammatory Drugs Sales, 2020-2025
6.3.2 By Region - Global Oral Nonsteroidal Anti-Inflammatory Drugs Sales, 2026-2032
6.3.3 By Region - Global Oral Nonsteroidal Anti-Inflammatory Drugs Sales Market Share, 2020-2032
6.4 North America
6.4.1 By Country - North America Oral Nonsteroidal Anti-Inflammatory Drugs Revenue, 2020-2032
6.4.2 By Country - North America Oral Nonsteroidal Anti-Inflammatory Drugs Sales, 2020-2032
6.4.3 United States Oral Nonsteroidal Anti-Inflammatory Drugs Market Size, 2020-2032
6.4.4 Canada Oral Nonsteroidal Anti-Inflammatory Drugs Market Size, 2020-2032
6.4.5 Mexico Oral Nonsteroidal Anti-Inflammatory Drugs Market Size, 2020-2032
6.5 Europe
6.5.1 By Country - Europe Oral Nonsteroidal Anti-Inflammatory Drugs Revenue, 2020-2032
6.5.2 By Country - Europe Oral Nonsteroidal Anti-Inflammatory Drugs Sales, 2020-2032
6.5.3 Germany Oral Nonsteroidal Anti-Inflammatory Drugs Market Size, 2020-2032
6.5.4 France Oral Nonsteroidal Anti-Inflammatory Drugs Market Size, 2020-2032
6.5.5 U.K. Oral Nonsteroidal Anti-Inflammatory Drugs Market Size, 2020-2032
6.5.6 Italy Oral Nonsteroidal Anti-Inflammatory Drugs Market Size, 2020-2032
6.5.7 Russia Oral Nonsteroidal Anti-Inflammatory Drugs Market Size, 2020-2032
6.5.8 Nordic Countries Oral Nonsteroidal Anti-Inflammatory Drugs Market Size, 2020-2032
6.5.9 Benelux Oral Nonsteroidal Anti-Inflammatory Drugs Market Size, 2020-2032
6.6 Asia
6.6.1 By Region - Asia Oral Nonsteroidal Anti-Inflammatory Drugs Revenue, 2020-2032
6.6.2 By Region - Asia Oral Nonsteroidal Anti-Inflammatory Drugs Sales, 2020-2032
6.6.3 China Oral Nonsteroidal Anti-Inflammatory Drugs Market Size, 2020-2032
6.6.4 Japan Oral Nonsteroidal Anti-Inflammatory Drugs Market Size, 2020-2032
6.6.5 South Korea Oral Nonsteroidal Anti-Inflammatory Drugs Market Size, 2020-2032
6.6.6 Southeast Asia Oral Nonsteroidal Anti-Inflammatory Drugs Market Size, 2020-2032
6.6.7 India Oral Nonsteroidal Anti-Inflammatory Drugs Market Size, 2020-2032
6.7 South America
6.7.1 By Country - South America Oral Nonsteroidal Anti-Inflammatory Drugs Revenue, 2020-2032
6.7.2 By Country - South America Oral Nonsteroidal Anti-Inflammatory Drugs Sales, 2020-2032
6.7.3 Brazil Oral Nonsteroidal Anti-Inflammatory Drugs Market Size, 2020-2032
6.7.4 Argentina Oral Nonsteroidal Anti-Inflammatory Drugs Market Size, 2020-2032
6.8 Middle East & Africa
6.8.1 By Country - Middle East & Africa Oral Nonsteroidal Anti-Inflammatory Drugs Revenue, 2020-2032
6.8.2 By Country - Middle East & Africa Oral Nonsteroidal Anti-Inflammatory Drugs Sales, 2020-2032
6.8.3 Turkey Oral Nonsteroidal Anti-Inflammatory Drugs Market Size, 2020-2032
6.8.4 Israel Oral Nonsteroidal Anti-Inflammatory Drugs Market Size, 2020-2032
6.8.5 Saudi Arabia Oral Nonsteroidal Anti-Inflammatory Drugs Market Size, 2020-2032
6.8.6 UAE Oral Nonsteroidal Anti-Inflammatory Drugs Market Size, 2020-2032
7 Manufacturers & Brands Profiles
7.1 Bayer AG
7.1.1 Bayer AG Company Summary
7.1.2 Bayer AG Business Overview
7.1.3 Bayer AG Oral Nonsteroidal Anti-Inflammatory Drugs Major Product Offerings
7.1.4 Bayer AG Oral Nonsteroidal Anti-Inflammatory Drugs Sales and Revenue in Global (2020-2025)
7.1.5 Bayer AG Key News & Latest Developments
7.2 Pfizer Inc
7.2.1 Pfizer Inc Company Summary
7.2.2 Pfizer Inc Business Overview
7.2.3 Pfizer Inc Oral Nonsteroidal Anti-Inflammatory Drugs Major Product Offerings
7.2.4 Pfizer Inc Oral Nonsteroidal Anti-Inflammatory Drugs Sales and Revenue in Global (2020-2025)
7.2.5 Pfizer Inc Key News & Latest Developments
7.3 Reckitt Benckiser Group PLC
7.3.1 Reckitt Benckiser Group PLC Company Summary
7.3.2 Reckitt Benckiser Group PLC Business Overview
7.3.3 Reckitt Benckiser Group PLC Oral Nonsteroidal Anti-Inflammatory Drugs Major Product Offerings
7.3.4 Reckitt Benckiser Group PLC Oral Nonsteroidal Anti-Inflammatory Drugs Sales and Revenue in Global (2020-2025)
7.3.5 Reckitt Benckiser Group PLC Key News & Latest Developments
7.4 Novartis AG
7.4.1 Novartis AG Company Summary
7.4.2 Novartis AG Business Overview
7.4.3 Novartis AG Oral Nonsteroidal Anti-Inflammatory Drugs Major Product Offerings
7.4.4 Novartis AG Oral Nonsteroidal Anti-Inflammatory Drugs Sales and Revenue in Global (2020-2025)
7.4.5 Novartis AG Key News & Latest Developments
7.5 DAIICHI SANKYO COMPANY, LIMITED
7.5.1 DAIICHI SANKYO COMPANY, LIMITED Company Summary
7.5.2 DAIICHI SANKYO COMPANY, LIMITED Business Overview
7.5.3 DAIICHI SANKYO COMPANY, LIMITED Oral Nonsteroidal Anti-Inflammatory Drugs Major Product Offerings
7.5.4 DAIICHI SANKYO COMPANY, LIMITED Oral Nonsteroidal Anti-Inflammatory Drugs Sales and Revenue in Global (2020-2025)
7.5.5 DAIICHI SANKYO COMPANY, LIMITED Key News & Latest Developments
7.6 Zydus Group
7.6.1 Zydus Group Company Summary
7.6.2 Zydus Group Business Overview
7.6.3 Zydus Group Oral Nonsteroidal Anti-Inflammatory Drugs Major Product Offerings
7.6.4 Zydus Group Oral Nonsteroidal Anti-Inflammatory Drugs Sales and Revenue in Global (2020-2025)
7.6.5 Zydus Group Key News & Latest Developments
7.7 Lupin
7.7.1 Lupin Company Summary
7.7.2 Lupin Business Overview
7.7.3 Lupin Oral Nonsteroidal Anti-Inflammatory Drugs Major Product Offerings
7.7.4 Lupin Oral Nonsteroidal Anti-Inflammatory Drugs Sales and Revenue in Global (2020-2025)
7.7.5 Lupin Key News & Latest Developments
7.8 GSK Plc
7.8.1 GSK Plc Company Summary
7.8.2 GSK Plc Business Overview
7.8.3 GSK Plc Oral Nonsteroidal Anti-Inflammatory Drugs Major Product Offerings
7.8.4 GSK Plc Oral Nonsteroidal Anti-Inflammatory Drugs Sales and Revenue in Global (2020-2025)
7.8.5 GSK Plc Key News & Latest Developments
7.9 Glenmark Pharmaceuticals Inc
7.9.1 Glenmark Pharmaceuticals Inc Company Summary
7.9.2 Glenmark Pharmaceuticals Inc Business Overview
7.9.3 Glenmark Pharmaceuticals Inc Oral Nonsteroidal Anti-Inflammatory Drugs Major Product Offerings
7.9.4 Glenmark Pharmaceuticals Inc Oral Nonsteroidal Anti-Inflammatory Drugs Sales and Revenue in Global (2020-2025)
7.9.5 Glenmark Pharmaceuticals Inc Key News & Latest Developments
7.10 Amneal Pharmaceuticals
7.10.1 Amneal Pharmaceuticals Company Summary
7.10.2 Amneal Pharmaceuticals Business Overview
7.10.3 Amneal Pharmaceuticals Oral Nonsteroidal Anti-Inflammatory Drugs Major Product Offerings
7.10.4 Amneal Pharmaceuticals Oral Nonsteroidal Anti-Inflammatory Drugs Sales and Revenue in Global (2020-2025)
7.10.5 Amneal Pharmaceuticals Key News & Latest Developments
7.11 AstraZeneca
7.11.1 AstraZeneca Company Summary
7.11.2 AstraZeneca Business Overview
7.11.3 AstraZeneca Oral Nonsteroidal Anti-Inflammatory Drugs Major Product Offerings
7.11.4 AstraZeneca Oral Nonsteroidal Anti-Inflammatory Drugs Sales and Revenue in Global (2020-2025)
7.11.5 AstraZeneca Key News & Latest Developments
7.12 Johnson & Johnson
7.12.1 Johnson & Johnson Company Summary
7.12.2 Johnson & Johnson Business Overview
7.12.3 Johnson & Johnson Oral Nonsteroidal Anti-Inflammatory Drugs Major Product Offerings
7.12.4 Johnson & Johnson Oral Nonsteroidal Anti-Inflammatory Drugs Sales and Revenue in Global (2020-2025)
7.12.5 Johnson & Johnson Key News & Latest Developments
8 Global Oral Nonsteroidal Anti-Inflammatory Drugs Production Capacity, Analysis
8.1 Global Oral Nonsteroidal Anti-Inflammatory Drugs Production Capacity, 2020-2032
8.2 Oral Nonsteroidal Anti-Inflammatory Drugs Production Capacity of Key Manufacturers in Global Market
8.3 Global Oral Nonsteroidal Anti-Inflammatory Drugs Production by Region
9 Key Market Trends, Opportunity, Drivers and Restraints
9.1 Market Opportunities & Trends
9.2 Market Drivers
9.3 Market Restraints
10 Oral Nonsteroidal Anti-Inflammatory Drugs Supply Chain Analysis
10.1 Oral Nonsteroidal Anti-Inflammatory Drugs Industry Value Chain
10.2 Oral Nonsteroidal Anti-Inflammatory Drugs Upstream Market
10.3 Oral Nonsteroidal Anti-Inflammatory Drugs Downstream and Clients
10.4 Marketing Channels Analysis
10.4.1 Marketing Channels
10.4.2 Oral Nonsteroidal Anti-Inflammatory Drugs Distributors and Sales Agents in Global
11 Conclusion
12 Appendix
12.1 Note
12.2 Examples of Clients
12.3 Disclaimer
Ask Our Expert

Leave This Empty:

*Required Information
List of Tables
Table 1. Key Players of Oral Nonsteroidal Anti-Inflammatory Drugs in Global Market
Table 2. Top Oral Nonsteroidal Anti-Inflammatory Drugs Players in Global Market, Ranking by Revenue (2024)
Table 3. Global Oral Nonsteroidal Anti-Inflammatory Drugs Revenue by Companies, (US$, Mn), 2020-2025
Table 4. Global Oral Nonsteroidal Anti-Inflammatory Drugs Revenue Share by Companies, 2020-2025
Table 5. Global Oral Nonsteroidal Anti-Inflammatory Drugs Sales by Companies, (K Units), 2020-2025
Table 6. Global Oral Nonsteroidal Anti-Inflammatory Drugs Sales Share by Companies, 2020-2025
Table 7. Key Manufacturers Oral Nonsteroidal Anti-Inflammatory Drugs Price (2020-2025) & (US$/Unit)
Table 8. Global Manufacturers Oral Nonsteroidal Anti-Inflammatory Drugs Product Type
Table 9. List of Global Tier 1 Oral Nonsteroidal Anti-Inflammatory Drugs Companies, Revenue (US$, Mn) in 2024 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Oral Nonsteroidal Anti-Inflammatory Drugs Companies, Revenue (US$, Mn) in 2024 and Market Share
Table 11. Segment by Type � Global Oral Nonsteroidal Anti-Inflammatory Drugs Revenue, (US$, Mn), 2024 & 2032
Table 12. Segment by Type - Global Oral Nonsteroidal Anti-Inflammatory Drugs Revenue (US$, Mn), 2020-2025
Table 13. Segment by Type - Global Oral Nonsteroidal Anti-Inflammatory Drugs Revenue (US$, Mn), 2026-2032
Table 14. Segment by Type - Global Oral Nonsteroidal Anti-Inflammatory Drugs Sales (K Units), 2020-2025
Table 15. Segment by Type - Global Oral Nonsteroidal Anti-Inflammatory Drugs Sales (K Units), 2026-2032
Table 16. Segment by Application � Global Oral Nonsteroidal Anti-Inflammatory Drugs Revenue, (US$, Mn), 2024 & 2032
Table 17. Segment by Application - Global Oral Nonsteroidal Anti-Inflammatory Drugs Revenue, (US$, Mn), 2020-2025
Table 18. Segment by Application - Global Oral Nonsteroidal Anti-Inflammatory Drugs Revenue, (US$, Mn), 2026-2032
Table 19. Segment by Application - Global Oral Nonsteroidal Anti-Inflammatory Drugs Sales, (K Units), 2020-2025
Table 20. Segment by Application - Global Oral Nonsteroidal Anti-Inflammatory Drugs Sales, (K Units), 2026-2032
Table 21. By Region � Global Oral Nonsteroidal Anti-Inflammatory Drugs Revenue, (US$, Mn), 2025-2032
Table 22. By Region - Global Oral Nonsteroidal Anti-Inflammatory Drugs Revenue, (US$, Mn), 2020-2025
Table 23. By Region - Global Oral Nonsteroidal Anti-Inflammatory Drugs Revenue, (US$, Mn), 2026-2032
Table 24. By Region - Global Oral Nonsteroidal Anti-Inflammatory Drugs Sales, (K Units), 2020-2025
Table 25. By Region - Global Oral Nonsteroidal Anti-Inflammatory Drugs Sales, (K Units), 2026-2032
Table 26. By Country - North America Oral Nonsteroidal Anti-Inflammatory Drugs Revenue, (US$, Mn), 2020-2025
Table 27. By Country - North America Oral Nonsteroidal Anti-Inflammatory Drugs Revenue, (US$, Mn), 2026-2032
Table 28. By Country - North America Oral Nonsteroidal Anti-Inflammatory Drugs Sales, (K Units), 2020-2025
Table 29. By Country - North America Oral Nonsteroidal Anti-Inflammatory Drugs Sales, (K Units), 2026-2032
Table 30. By Country - Europe Oral Nonsteroidal Anti-Inflammatory Drugs Revenue, (US$, Mn), 2020-2025
Table 31. By Country - Europe Oral Nonsteroidal Anti-Inflammatory Drugs Revenue, (US$, Mn), 2026-2032
Table 32. By Country - Europe Oral Nonsteroidal Anti-Inflammatory Drugs Sales, (K Units), 2020-2025
Table 33. By Country - Europe Oral Nonsteroidal Anti-Inflammatory Drugs Sales, (K Units), 2026-2032
Table 34. By Region - Asia Oral Nonsteroidal Anti-Inflammatory Drugs Revenue, (US$, Mn), 2020-2025
Table 35. By Region - Asia Oral Nonsteroidal Anti-Inflammatory Drugs Revenue, (US$, Mn), 2026-2032
Table 36. By Region - Asia Oral Nonsteroidal Anti-Inflammatory Drugs Sales, (K Units), 2020-2025
Table 37. By Region - Asia Oral Nonsteroidal Anti-Inflammatory Drugs Sales, (K Units), 2026-2032
Table 38. By Country - South America Oral Nonsteroidal Anti-Inflammatory Drugs Revenue, (US$, Mn), 2020-2025
Table 39. By Country - South America Oral Nonsteroidal Anti-Inflammatory Drugs Revenue, (US$, Mn), 2026-2032
Table 40. By Country - South America Oral Nonsteroidal Anti-Inflammatory Drugs Sales, (K Units), 2020-2025
Table 41. By Country - South America Oral Nonsteroidal Anti-Inflammatory Drugs Sales, (K Units), 2026-2032
Table 42. By Country - Middle East & Africa Oral Nonsteroidal Anti-Inflammatory Drugs Revenue, (US$, Mn), 2020-2025
Table 43. By Country - Middle East & Africa Oral Nonsteroidal Anti-Inflammatory Drugs Revenue, (US$, Mn), 2026-2032
Table 44. By Country - Middle East & Africa Oral Nonsteroidal Anti-Inflammatory Drugs Sales, (K Units), 2020-2025
Table 45. By Country - Middle East & Africa Oral Nonsteroidal Anti-Inflammatory Drugs Sales, (K Units), 2026-2032
Table 46. Bayer AG Company Summary
Table 47. Bayer AG Oral Nonsteroidal Anti-Inflammatory Drugs Product Offerings
Table 48. Bayer AG Oral Nonsteroidal Anti-Inflammatory Drugs Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) & (2020-2025)
Table 49. Bayer AG Key News & Latest Developments
Table 50. Pfizer Inc Company Summary
Table 51. Pfizer Inc Oral Nonsteroidal Anti-Inflammatory Drugs Product Offerings
Table 52. Pfizer Inc Oral Nonsteroidal Anti-Inflammatory Drugs Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) & (2020-2025)
Table 53. Pfizer Inc Key News & Latest Developments
Table 54. Reckitt Benckiser Group PLC Company Summary
Table 55. Reckitt Benckiser Group PLC Oral Nonsteroidal Anti-Inflammatory Drugs Product Offerings
Table 56. Reckitt Benckiser Group PLC Oral Nonsteroidal Anti-Inflammatory Drugs Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) & (2020-2025)
Table 57. Reckitt Benckiser Group PLC Key News & Latest Developments
Table 58. Novartis AG Company Summary
Table 59. Novartis AG Oral Nonsteroidal Anti-Inflammatory Drugs Product Offerings
Table 60. Novartis AG Oral Nonsteroidal Anti-Inflammatory Drugs Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) & (2020-2025)
Table 61. Novartis AG Key News & Latest Developments
Table 62. DAIICHI SANKYO COMPANY, LIMITED Company Summary
Table 63. DAIICHI SANKYO COMPANY, LIMITED Oral Nonsteroidal Anti-Inflammatory Drugs Product Offerings
Table 64. DAIICHI SANKYO COMPANY, LIMITED Oral Nonsteroidal Anti-Inflammatory Drugs Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) & (2020-2025)
Table 65. DAIICHI SANKYO COMPANY, LIMITED Key News & Latest Developments
Table 66. Zydus Group Company Summary
Table 67. Zydus Group Oral Nonsteroidal Anti-Inflammatory Drugs Product Offerings
Table 68. Zydus Group Oral Nonsteroidal Anti-Inflammatory Drugs Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) & (2020-2025)
Table 69. Zydus Group Key News & Latest Developments
Table 70. Lupin Company Summary
Table 71. Lupin Oral Nonsteroidal Anti-Inflammatory Drugs Product Offerings
Table 72. Lupin Oral Nonsteroidal Anti-Inflammatory Drugs Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) & (2020-2025)
Table 73. Lupin Key News & Latest Developments
Table 74. GSK Plc Company Summary
Table 75. GSK Plc Oral Nonsteroidal Anti-Inflammatory Drugs Product Offerings
Table 76. GSK Plc Oral Nonsteroidal Anti-Inflammatory Drugs Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) & (2020-2025)
Table 77. GSK Plc Key News & Latest Developments
Table 78. Glenmark Pharmaceuticals Inc Company Summary
Table 79. Glenmark Pharmaceuticals Inc Oral Nonsteroidal Anti-Inflammatory Drugs Product Offerings
Table 80. Glenmark Pharmaceuticals Inc Oral Nonsteroidal Anti-Inflammatory Drugs Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) & (2020-2025)
Table 81. Glenmark Pharmaceuticals Inc Key News & Latest Developments
Table 82. Amneal Pharmaceuticals Company Summary
Table 83. Amneal Pharmaceuticals Oral Nonsteroidal Anti-Inflammatory Drugs Product Offerings
Table 84. Amneal Pharmaceuticals Oral Nonsteroidal Anti-Inflammatory Drugs Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) & (2020-2025)
Table 85. Amneal Pharmaceuticals Key News & Latest Developments
Table 86. AstraZeneca Company Summary
Table 87. AstraZeneca Oral Nonsteroidal Anti-Inflammatory Drugs Product Offerings
Table 88. AstraZeneca Oral Nonsteroidal Anti-Inflammatory Drugs Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) & (2020-2025)
Table 89. AstraZeneca Key News & Latest Developments
Table 90. Johnson & Johnson Company Summary
Table 91. Johnson & Johnson Oral Nonsteroidal Anti-Inflammatory Drugs Product Offerings
Table 92. Johnson & Johnson Oral Nonsteroidal Anti-Inflammatory Drugs Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) & (2020-2025)
Table 93. Johnson & Johnson Key News & Latest Developments
Table 94. Oral Nonsteroidal Anti-Inflammatory Drugs Capacity of Key Manufacturers in Global Market, 2023-2025 (K Units)
Table 95. Global Oral Nonsteroidal Anti-Inflammatory Drugs Capacity Market Share of Key Manufacturers, 2023-2025
Table 96. Global Oral Nonsteroidal Anti-Inflammatory Drugs Production by Region, 2020-2025 (K Units)
Table 97. Global Oral Nonsteroidal Anti-Inflammatory Drugs Production by Region, 2026-2032 (K Units)
Table 98. Oral Nonsteroidal Anti-Inflammatory Drugs Market Opportunities & Trends in Global Market
Table 99. Oral Nonsteroidal Anti-Inflammatory Drugs Market Drivers in Global Market
Table 100. Oral Nonsteroidal Anti-Inflammatory Drugs Market Restraints in Global Market
Table 101. Oral Nonsteroidal Anti-Inflammatory Drugs Raw Materials
Table 102. Oral Nonsteroidal Anti-Inflammatory Drugs Raw Materials Suppliers in Global Market
Table 103. Typical Oral Nonsteroidal Anti-Inflammatory Drugs Downstream
Table 104. Oral Nonsteroidal Anti-Inflammatory Drugs Downstream Clients in Global Market
Table 105. Oral Nonsteroidal Anti-Inflammatory Drugs Distributors and Sales Agents in Global Market


List of Figures
Figure 1. Oral Nonsteroidal Anti-Inflammatory Drugs Product Picture
Figure 2. Oral Nonsteroidal Anti-Inflammatory Drugs Segment by Type in 2024
Figure 3. Oral Nonsteroidal Anti-Inflammatory Drugs Segment by Application in 2024
Figure 4. Global Oral Nonsteroidal Anti-Inflammatory Drugs Market Overview: 2024
Figure 5. Key Caveats
Figure 6. Global Oral Nonsteroidal Anti-Inflammatory Drugs Market Size: 2024 VS 2032 (US$, Mn)
Figure 7. Global Oral Nonsteroidal Anti-Inflammatory Drugs Revenue: 2020-2032 (US$, Mn)
Figure 8. Oral Nonsteroidal Anti-Inflammatory Drugs Sales in Global Market: 2020-2032 (K Units)
Figure 9. The Top 3 and 5 Players Market Share by Oral Nonsteroidal Anti-Inflammatory Drugs Revenue in 2024
Figure 10. Segment by Type � Global Oral Nonsteroidal Anti-Inflammatory Drugs Revenue, (US$, Mn), 2024 & 2032
Figure 11. Segment by Type - Global Oral Nonsteroidal Anti-Inflammatory Drugs Revenue Market Share, 2020-2032
Figure 12. Segment by Type - Global Oral Nonsteroidal Anti-Inflammatory Drugs Sales Market Share, 2020-2032
Figure 13. Segment by Type - Global Oral Nonsteroidal Anti-Inflammatory Drugs Price (US$/Unit), 2020-2032
Figure 14. Segment by Application � Global Oral Nonsteroidal Anti-Inflammatory Drugs Revenue, (US$, Mn), 2024 & 2032
Figure 15. Segment by Application - Global Oral Nonsteroidal Anti-Inflammatory Drugs Revenue Market Share, 2020-2032
Figure 16. Segment by Application - Global Oral Nonsteroidal Anti-Inflammatory Drugs Sales Market Share, 2020-2032
Figure 17. Segment by Application -Global Oral Nonsteroidal Anti-Inflammatory Drugs Price (US$/Unit), 2020-2032
Figure 18. By Region � Global Oral Nonsteroidal Anti-Inflammatory Drugs Revenue, (US$, Mn), 2025 & 2032
Figure 19. By Region - Global Oral Nonsteroidal Anti-Inflammatory Drugs Revenue Market Share, 2020 VS 2024 VS 2032
Figure 20. By Region - Global Oral Nonsteroidal Anti-Inflammatory Drugs Revenue Market Share, 2020-2032
Figure 21. By Region - Global Oral Nonsteroidal Anti-Inflammatory Drugs Sales Market Share, 2020-2032
Figure 22. By Country - North America Oral Nonsteroidal Anti-Inflammatory Drugs Revenue Market Share, 2020-2032
Figure 23. By Country - North America Oral Nonsteroidal Anti-Inflammatory Drugs Sales Market Share, 2020-2032
Figure 24. United States Oral Nonsteroidal Anti-Inflammatory Drugs Revenue, (US$, Mn), 2020-2032
Figure 25. Canada Oral Nonsteroidal Anti-Inflammatory Drugs Revenue, (US$, Mn), 2020-2032
Figure 26. Mexico Oral Nonsteroidal Anti-Inflammatory Drugs Revenue, (US$, Mn), 2020-2032
Figure 27. By Country - Europe Oral Nonsteroidal Anti-Inflammatory Drugs Revenue Market Share, 2020-2032
Figure 28. By Country - Europe Oral Nonsteroidal Anti-Inflammatory Drugs Sales Market Share, 2020-2032
Figure 29. Germany Oral Nonsteroidal Anti-Inflammatory Drugs Revenue, (US$, Mn), 2020-2032
Figure 30. France Oral Nonsteroidal Anti-Inflammatory Drugs Revenue, (US$, Mn), 2020-2032
Figure 31. U.K. Oral Nonsteroidal Anti-Inflammatory Drugs Revenue, (US$, Mn), 2020-2032
Figure 32. Italy Oral Nonsteroidal Anti-Inflammatory Drugs Revenue, (US$, Mn), 2020-2032
Figure 33. Russia Oral Nonsteroidal Anti-Inflammatory Drugs Revenue, (US$, Mn), 2020-2032
Figure 34. Nordic Countries Oral Nonsteroidal Anti-Inflammatory Drugs Revenue, (US$, Mn), 2020-2032
Figure 35. Benelux Oral Nonsteroidal Anti-Inflammatory Drugs Revenue, (US$, Mn), 2020-2032
Figure 36. By Region - Asia Oral Nonsteroidal Anti-Inflammatory Drugs Revenue Market Share, 2020-2032
Figure 37. By Region - Asia Oral Nonsteroidal Anti-Inflammatory Drugs Sales Market Share, 2020-2032
Figure 38. China Oral Nonsteroidal Anti-Inflammatory Drugs Revenue, (US$, Mn), 2020-2032
Figure 39. Japan Oral Nonsteroidal Anti-Inflammatory Drugs Revenue, (US$, Mn), 2020-2032
Figure 40. South Korea Oral Nonsteroidal Anti-Inflammatory Drugs Revenue, (US$, Mn), 2020-2032
Figure 41. Southeast Asia Oral Nonsteroidal Anti-Inflammatory Drugs Revenue, (US$, Mn), 2020-2032
Figure 42. India Oral Nonsteroidal Anti-Inflammatory Drugs Revenue, (US$, Mn), 2020-2032
Figure 43. By Country - South America Oral Nonsteroidal Anti-Inflammatory Drugs Revenue Market Share, 2020-2032
Figure 44. By Country - South America Oral Nonsteroidal Anti-Inflammatory Drugs Sales, Market Share, 2020-2032
Figure 45. Brazil Oral Nonsteroidal Anti-Inflammatory Drugs Revenue, (US$, Mn), 2020-2032
Figure 46. Argentina Oral Nonsteroidal Anti-Inflammatory Drugs Revenue, (US$, Mn), 2020-2032
Figure 47. By Country - Middle East & Africa Oral Nonsteroidal Anti-Inflammatory Drugs Revenue, Market Share, 2020-2032
Figure 48. By Country - Middle East & Africa Oral Nonsteroidal Anti-Inflammatory Drugs Sales, Market Share, 2020-2032
Figure 49. Turkey Oral Nonsteroidal Anti-Inflammatory Drugs Revenue, (US$, Mn), 2020-2032
Figure 50. Israel Oral Nonsteroidal Anti-Inflammatory Drugs Revenue, (US$, Mn), 2020-2032
Figure 51. Saudi Arabia Oral Nonsteroidal Anti-Inflammatory Drugs Revenue, (US$, Mn), 2020-2032
Figure 52. UAE Oral Nonsteroidal Anti-Inflammatory Drugs Revenue, (US$, Mn), 2020-2032
Figure 53. Global Oral Nonsteroidal Anti-Inflammatory Drugs Production Capacity (K Units), 2020-2032
Figure 54. The Percentage of Production Oral Nonsteroidal Anti-Inflammatory Drugs by Region, 2024 VS 2032
Figure 55. Oral Nonsteroidal Anti-Inflammatory Drugs Industry Value Chain
Figure 56. Marketing Channels

Buy Full Report

Select Licence type with your requirement and needs

SECURITY ASSUREDpayment image

analyst icon
Still not found what you want?

Speak to our Custom Research Team and get the Custom Research in a budget

Custom Research


Frequently Asked Questions ?

  • A license granted to one user.

    A license granted to one user. Rules or conditions might be applied for e.g. the use of electric files (PDFs) or printings, depending on product.

  • Multi user License

    A license granted to multiple users.

  • Site License

    A license granted to a single business site/establishment.

  • Corporate License, Global License

    A license granted to all employees within organisation access to the product.

  • Upto Working 24 to 48 hrs

  • Upto 72 hrs max - Weekends and Public Holidays

  • Online Payments with PayPal and CCavenue

  • Wire Transfer/Bank Transfer

  • Email

  • Hard Copy

WHY CHOOSE US

  • Proactive We manage our resources 24/7 to identify issues and address them before they become problems
  • Quality & Reliability We are committed to providing reliable and highly accurate data with an excellent quality control system
  • Global Outreach 6 Major regions and 40+ countries level analysis accomplished
  • Competitive Pricing Our pricing strategy is highly competitive in the market, without compensating on the quality and the timeline of project delivery

SOME OF OUR CLIENTS
WHAT SET US APART?
  • quilty

    Quality Assurance

    Focus on Data Accuracy & Reliability
  • quilty

    Trusted by the Best

    75+ Clients in Fortune 500
  • quilty

    Privacy and Security

    All your transactions are secured end-to-end, ensuring a satisfactory purchase
  • quilty

    Competitive Pricing

    Ensure the best and affordable pricing
OUR HAPPY CUSTOMER Some of our customer review
Stay Updated About Oral Nonsteroidal Anti-Inflammatory Drugs and Forecast Market

Leave This Empty: